The following Life Sciences guidance note provides comprehensive and up to date legal information covering:
On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period during which it continues to be treated by the EU as a Member State for many purposes. As a third country, the UK can no longer participate in the EU’s political institutions, agencies, offices, bodies (except to the limited extent agreed), but it continues to be subject to EU law and must submit to the continuing jurisdiction of the Court of Justice of the EU in accordance with the transitional arrangements in Part 4 of the Withdrawal Agreement. For further reading, see: Brexit—Life Sciences and News Analysis: Brexit Bulletin—key updates, research tips and resources.
Products sold to consumers must be safe. In the UK, product safety is governed by a wide legal and regulatory framework, with certain high-risk products, such as medicines, being subject to additional regulation.
Failure to comply with these laws can lead to both civil and criminal liability.
Civil product liability can be based on:
strict liability (as a result of a defect in a product rather than any fault on the part of the defendant) under Directive 85/374/EEC, the Product Liability Directive
negligence (fault-based liability where a duty of care has been breached and resulted in damage) under the common law of tort
breach of contract
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234